IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 148 filers reported holding IMMUNITYBIO INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17 | +13.3% | 2,620 | -4.0% | 0.00% | – |
| Q1 2024 | $15 | +7.1% | 2,730 | 0.0% | 0.00% | – |
| Q4 2023 | $14 | +366.7% | 2,730 | +69.6% | 0.00% | – |
| Q3 2023 | $3 | -25.0% | 1,610 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | +33.3% | 1,610 | 0.0% | 0.00% | – |
| Q1 2023 | $3 | -62.5% | 1,610 | 0.0% | 0.00% | – |
| Q4 2022 | $8 | -99.9% | 1,610 | +8.6% | 0.00% | – |
| Q3 2022 | $7,000 | -92.6% | 1,483 | -94.2% | 0.00% | -100.0% |
| Q2 2022 | $95,000 | -24.6% | 25,589 | +14.1% | 0.00% | 0.0% |
| Q1 2022 | $126,000 | +31.2% | 22,432 | +42.4% | 0.00% | 0.0% |
| Q4 2021 | $96,000 | +68.4% | 15,756 | +170.7% | 0.00% | – |
| Q3 2021 | $57,000 | +418.2% | 5,820 | +680.2% | 0.00% | – |
| Q2 2021 | $11,000 | +120.0% | 746 | +245.4% | 0.00% | – |
| Q1 2021 | $5,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
| ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
| Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
| SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
| Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
| Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
| Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
| Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |